Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Regeneron Pharmaceuticals agreed to buy DNA testing company 23andMe in a bankruptcy court auction, the company said Monday.

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.

Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...

international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock. Fortinet ( NASDAQ:FTNT ) First Quarter 2025 ...

which tends to hurt stock performance. The strategy also had less exposure to highly liquid stocks compared with Morningstar Category peers in recent months. Less-liquid stocks might offer strong ...

Crypto investment firm and asset manager Galaxy Digital (GLXY) debuted on the Nasdaq on Friday, moving from the Toronto Stock Exchange ... Mark Palmer weighs in on whether Coinbase's lackluster ...